PTC Inc.
PTC | NASDAQ
$137.36
+$2.08 (+1.54%)
Sep 22, 2026, 2:37 PM ET · Market open
Company Profile
PTC Inc. operates as a global provider of software and services, with its market presence extending across the Americas, Europe, and the Asia Pacific regions. The company's business is organized into two primary divisions: Software Products and Professional Services. Among its key offerings is the ThingWorx platform, which furnishes enterprises with a suite of functionalities to drive digital innovation across their operations. These solutions are characterized by ease of creation and deployment, scalability for future demands, and their ability to accelerate value realization for customers. Another significant product, Vuforia, enables the visualization of digital information within real-world contexts and facilitates the development of augmented reality applications. PTC also delivers Onshape, a cloud-based product development platform that seamlessly integrates computer-aided design with robust data management, collaborative tools, and real-time analytical capabilities. For product lifecycle management (PLM), the company provides Arena, a solution designed to empower product teams to collaborate virtually from any location, and Windchill, another comprehensive PLM software. Furthermore, Creo stands as a leading 3D CAD technology, supporting the digital design, validation, and refinement of product models. Additional specialized software includes Integrity, an application lifecycle management solution, and Servigistics, focused on optimizing service parts management. Beyond its software portfolio, PTC offers an extensive array of professional services, encompassing consulting, implementation support, training programs, cloud solutions, and ongoing licensing and technical assistance. Established in 1985 and headquartered in Boston, Massachusetts, the company was originally named Parametric Technology Corporation before officially rebranding as PTC Inc. in January 2013.
Key Executives
| Name | Position |
|---|---|
| Neil Barua | President, Chief Executive Officer & Director |
| Beth Conway | Executive Vice President & Chief People Officer |
| Jennifer DiRico | Executive Vice President & Chief Financial Officer |
| Aaron C. Von Staats | Executive Vice President, General Counsel & Corporate Secretary |
| Alice Christenson | Chief Accounting Officer |
| Amit Jain | Chief Strategy Officer |
| Catherine A. Kniker | EVice President, Chief Marketing & Sustainability Officer |
| Catherine Gorecki | Senior Vice President of Corporate & Securities Counsel and Assistant Secretary |
| Matthew Shimao | Senior Vice President of Investor Relations |
| Michael Donald Maguire | Head of Investor Relations |
| Robert Dahdah | Executive VP & Chief Revenue Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 17, 2026 | 4 | Filing |
| Aug 17, 2026 | 4 | Filing |
| Aug 14, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 07, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Jul 31, 2026 | 10-Q | Quarterly Report |
| Jul 29, 2026 | 8-K | Current Report |
| May 15, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| May 12, 2026 | 4 | Filing |
| May 08, 2026 | 4 | Filing |
| May 07, 2026 | 10-Q | Quarterly Report |
PTC Inc.
| Country | United States |
| IPO Date | Dec 7, 1989 |
| Industry | Software - Application |
| Sector | Technology |
| Employees | 7,000 |
| CEO | Neil Barua |
Contact Details
121 Seaport Boulevard Boston,
Massachusetts 02210 United States
Stock Details
| Ticker Symbol | PTC |
| Exchange | NASDAQ |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| CIK Code | 0000857005 |
| CUSIP Number | 69370C100 |
| ISIN Number | US69370C1009 |
| SIC Code | 7372 |
Recent News
- 1 day ago / prnewswire.comPTC Completes Acquisition of ST-920 Fabry Disease Gene Therapy
- 7 days ago / prnewswire.comPTC's Creo and Windchill Solutions Selected for Product Development across Fisica Applied Technologies
- 13 days ago / seekingalpha.comPTC Inc. (PTC) Presents at Citi's 2026 Global TMT Conference Transcript
- 25 days ago / zacks.comPTC Inc. (PTC) Up 16.6% Since Last Earnings Report: Can It Continue?
- 26 days ago / prnewswire.comPTC Therapeutics to Participate in Upcoming Investor Conferences
- 29 days ago / prnewswire.comPTC Therapeutics Announces New Sephience™ (sepiapterin) Data Reinforcing Broad Patient Benefits Including Sustained Metabolic Control and Diet Liberalization as well as Consistent Favorable Safety Profile
- 30 days ago / seekingalpha.comPTC Therapeutics: An Acquisition Which Could Unlock Massive Potential
- 1 month ago / benzinga.comPTC Therapeutics Expands Rare Disease Portfolio with 'Unique Opportunity'
- 1 month ago / prnewswire.comPTC Advances Leadership in AI-Driven Design with Launch of Onshape FeatureScript MCP Server
- 1 month ago / prnewswire.comPTC to Expand Rare Disease Portfolio with Acquisition of BLA-Stage ST-920 Fabry Disease Program
Add to Watchlist
Select watchlists to add or remove PTC